Coagulation, inflammation, and the risk of neonatal white matter damage

Area of Science:

• Biomedical Science
• Neuroscience
• Hematology

Background:

• Systemic inflammation is linked to increased coagulation activation markers in newborns and adults.
• Coagulation factors can worsen inflammation, creating a detrimental cycle.
• Current therapies targeting only coagulation or inflammation have failed to reduce mortality in severe systemic inflammatory response syndrome and multi-organ dysfunction (SIRS/MOD).

Purpose of the Study:

• To investigate the role of activated coagulation factors in neonatal cerebral white matter damage.
• To propose a mechanism by which coagulation contributes to inflammation-induced brain injury in at-risk newborns.

Main Methods:

• Review of existing literature on coagulation, inflammation, and neonatal brain injury.
• Analysis of the relationship between systemic inflammatory response, coagulation factors, and cerebral white matter damage in newborns.
• Comparison of therapeutic outcomes in SIRS/MOD.

Main Results:

• Activated coagulation factors appear to exacerbate inflammation.
• Activated protein C, with both anti-coagulant and anti-inflammatory effects, is the only therapy shown to reduce mortality in SIRS/MOD.
• Newborns at risk for cerebral white matter damage often exhibit systemic inflammation with elevated coagulation factors.

Conclusions:

• Activated coagulation factors likely contribute to neonatal cerebral white matter damage by enhancing inflammatory processes.
• The mechanism is suggested to be inflammation exacerbation rather than direct blood vessel occlusion.
• This understanding may guide novel therapeutic strategies for preventing neonatal brain injury.